NCT05745519

Brief Summary

Discuss the objective assessment of patients with insomnia by pulse diagnosis, and measure by subjective questionnaire and physiological instruments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 27, 2023

Completed
Last Updated

February 27, 2023

Status Verified

February 1, 2023

Enrollment Period

11 months

First QC Date

February 16, 2023

Last Update Submit

February 16, 2023

Conditions

Keywords

InsomniaPulseHeart rate variability

Outcome Measures

Primary Outcomes (1)

  • Pittsburgh sleep quality index (PSQI)

    Pittsburgh sleep quality index (PSQI)

    15 minutes

Secondary Outcomes (5)

  • Hospital Anxiety and Depression Scale (HADS)

    15 minutes

  • Epworth Sleepiness Scale (ESS)

    15 minutes

  • The Green Climacteric Scale(GCS)

    15 minutes

  • General Sleep Disturbance Scale(GSDS)

    15 minutes

  • Constitution in Chinese Medicine Questionnaire (CCMQ)

    15 minutes

Study Arms (2)

The experimental group

Aged 40-79 years old, complained of insomnia symptoms in the past month, at least three times a week, for a month, such as: difficulty falling asleep, waking up in the middle of the night, waking up unable to fall asleep, waking up in the morning and still not getting enough sleep

Other: Pittsburgh sleep quality index (PSQI)Device: ANSWatch

The control group

Healthy volunteer subjects aged 40-79 without insomnia.

Other: Pittsburgh sleep quality index (PSQI)Device: ANSWatch

Interventions

The scale is suitable for the evaluation of sleep quality in patients with sleep disorders and mental disorders, as well as for the evaluation of sleep quality in general people.

The control groupThe experimental group
ANSWatchDEVICE

Measure eight physiological parameters including heartbeat, systolic blood pressure, diastolic blood pressure, heart rhythm variability HRV, low frequency component LF, high frequency component HF, LF/HF low frequency high frequency component ratio, and irregular heartbeat within five minutes

The control groupThe experimental group

Eligibility Criteria

Age40 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

In the experimental group, select subjects who meet the following conditions: aged 40-79 years, who complained of insomnia symptoms in the past month, at least three times a week for one month, such as: difficulty falling asleep, waking up in the middle of the night, unable to wake up Falling asleep, waking up in the morning still feeling sleepy. Control group: healthy voluntary subjects aged 40-79 without insomnia.

You may qualify if:

  • aged 40-60 years
  • Complaints of insomnia symptoms in the past month that lasted for at least one week, such as difficulty falling asleep, waking up easily in the middle of the night, unable to fall asleep after waking up, still not getting enough sleep after waking up in the morning
  • The score of sleep disorder on the Pittsburgh Sleep Quality Scale was more than 5 points

You may not qualify if:

  • History of psychiatric disorders
  • History of sleep apnea or nocturnal myoclonus
  • Center or neurodegenerative disease
  • Cancer
  • Melatonin or sleeping pills use in the past month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ministry of Health and Welfare Tainan Hospital

Tainan, 700007, Taiwan

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2023

First Posted

February 27, 2023

Study Start

January 1, 2022

Primary Completion

December 1, 2022

Study Completion

December 31, 2022

Last Updated

February 27, 2023

Record last verified: 2023-02

Locations